草莓缺刻同源基因1和2在人胶质母细胞瘤中的表达研究
本研究旨在全面记录草莓缺刻同源基因(SBNO)1和2在胶质母细胞瘤(GBM)组织及患者来源GBM干细胞样细胞(GSC)培养物中的表达。通过免疫染色和qPCR分析组织与GSC中的RNA和蛋白表达,并利用公共数据集评估基因表达及拷贝数改变。结果显示SBNO2在GBM组织中表达升高,而SBNO1表达不变,SBNO2过表达在不同患者来源GSC中诱导不同表型。
要点
- SBNO2在GBM组织中表达高于非肿瘤脑组织和低级别胶质瘤,SBNO1表达不变。
- SBNO2高表达可能与19p13染色体区域拷贝数改变有关。
- SBNO1和SBNO2定位于不同亚细胞组分,SBNO2过表达在不同GSC中诱导不同表型。
核心结论
- SBNO2在GBM中高表达,SBNO1表达不变,这是首次对SBNO1和SBNO2在胶质瘤组织中表达的表征。
研究设计与样本
- 研究检测胶质瘤患者组织和患者来源GBM干细胞样细胞(GSC)中SBNO1和SBNO2的RNA及蛋白表达,采用免疫染色和qPCR分析,并使用公共数据集评估基因表达和拷贝数改变,通过慢病毒转导SBNO2分析其在GSC中的效应。
主要发现
- SBNO2在GBM组织样本中表达高于非肿瘤脑组织或低级别胶质瘤,而SBNO1表达保持不变。
- 作者推测SBNO2高表达可能与19p13染色体区域拷贝数改变有关。
- SBNO1和SBNO2定位于不同亚细胞组分。
- SBNO2过表达在不同患者来源GSC中诱导不同表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In this work, we aimed to comprehensively document the expression of Strawberry Notch homolog (SBNO) 1 and 2 in glioblastoma (GBM) tissue and patient-derived GBM stem-like cell (GSC) cultures. METHODS: We investigated SBNO1 and SBNO2 expression at the RNA and protein levels in glioma patient tissue and GSCs, respectively by performing immunostainings and qPCR analyses. We also used publicly-available datasets for assessing SBNO1 and SBNO2 gene expression and related copy number alterations. We used lentiviral transduction of SBNO2 to analyze the effect of its expression in patient-derived GSCs. RESULTS: We observed that SBNO2 expression is increased in GBM tissue samples compared to non tumoral brain, or lower-grade gliomas, whereas SBNO1 expression remains unchanged. We hypothesized that such SBNO2 high expression might be linked to copy-number alterations at the level of the 19p13 chromosome section. We located SBNO1 and SBNO2 in different subcellular compartments. Finally, we observed that SBNO2 overexpression induces different phenotypes in different patient-derived GSCs. CONCLUSION: These results provide the first characterization of SBNO1 and SBNO2 expression in glioma tissue, and indicate SBNO2 as highly expressed in GBM.
引用
- Coppieters N, Scalisi J, Digregorio M, et al. Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. J Neurooncol. 2023. PMID: 36695974. doi:10.1007/s11060-023-04240-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。